Cytosorbents (CTSO) Net Margin (2011 - 2026)
Cytosorbents (CTSO) posted Net Margin of 57.86% for Q1 2026, up 2.8% on a QoQ basis from 59.53% in Q4 2025, and down 4092.0% year-over-year from 1.45% in Q1 2025.
Cytosorbents (CTSO) Net Margin (2011 - 2026) Analysis & Trends
Cytosorbents' Net Margin history runs 16 years deep, the most recent figure standing at 57.86% for Q1 2026.
- Quarterly Net Margin fell 4092.0% year-over-year to 57.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 31.85% (up 1374.0% YoY) and the FY2025 annual result came in at 22.12%, up 3609.0% from the prior year.
- Net Margin was 57.86% for Q1 2026 at Cytosorbents, up from 59.53% in the prior quarter.
- Across five years, Net Margin topped out at 20.25% in Q2 2025 and bottomed at 150.42% in Q3 2022.
- A 5-year average of 63.88% and a median of 65.31% in 2023 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 7816 bps in 2022, while the deepest fall reached 8916 bps in 2022.
- Cytosorbents' Net Margin stood at 8.16% in 2022, then slumped by 725 bps to 67.31% in 2023, then dropped by 23 bps to 82.69% in 2024, then climbed by 28 bps to 59.53% in 2025, then climbed by 3 bps to 57.86% in 2026.
- Business Quant data shows CTSO's Net Margin at 57.86% in Q1 2026, 59.53% in Q4 2025, and 33.42% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -57.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.86% |
| Dec 31, 2025 | -59.53% |
| Sep 30, 2025 | -33.42% |
| Jun 30, 2025 | 20.25% |
| Mar 31, 2025 | -16.95% |
| Dec 31, 2024 | -82.69% |
| Sep 30, 2024 | -32.14% |
| Jun 30, 2024 | -48.56% |
| Mar 31, 2024 | -70.73% |
| Dec 31, 2023 | -67.31% |
| Sep 30, 2023 | -104.34% |
| Jun 30, 2023 | -65.31% |
| Mar 31, 2023 | -77.53% |
| Dec 31, 2022 | -8.16% |
| Sep 30, 2022 | -150.42% |
| Jun 30, 2022 | -128.06% |
| Mar 31, 2022 | -103.16% |
| Dec 31, 2021 | -86.32% |
| Sep 30, 2021 | -65.64% |
| Jun 30, 2021 | -38.90% |